即时检测(POCT)可突破检测环境和人员的限制,为患者的治疗和管理提供便捷、经济的解决方案,在传染病检测和预防方面优势明显,是传染病防控的有力工具。得益于国家政策扶持以及企业技术积累,截至2020年4月11日,总计有6款新型冠状病毒抗体检测试剂(胶体金法)和4款分子POCT检测试剂上市。本文对POCT在传染病防控中的技术平台及市场情况进行了介绍,重点阐述了POCT产品在全球突发新冠肺炎疫情中的应用方向,并对POCT在突发传染病疫情防控中的价值以及未来的发展进行了思考,包括应急产品质量管理体系优化、产学研协同合作、分子POCT和多项目联检技术的发展、应用场景的多元化拓展、POCT数字化创新等。
<<POCT can break through the limitation of testing environment and personnel,provide convenient and economical solution for patients’ treatment and management,have obvious advantage in detecting and preventing infectious diseases,and it is a powerful tool for preventing and controlling infectious diseases. Thanks to the national policy support and enterprise technology accumulation,as of April 11,2020,a total of 6 new coronavirus antibody detection reagent (colloidal gold method)and 4 molecular POCT detection reagent listed. This paper introduces the technical platform and market situation of POCT in the prevention and control of infectious diseases,focuses on the application direction of POCT products in the global outbreak of COVID-19,and thinks about the value and development trend of POCT in the prevention and control of infectious diseases,such as the optimization of emergency product quality management system,the cooperation of production,education and research,the development of molecular diagnosis POCT and multi-project joint inspection technology,the diversification of application scenario and digital innovation of POCT.
<<Keywords: | COVID-19Instant DetectionDiagnosis POCT |